Amazon Great Indian Festival 2020 - Electronics
Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Amazon Great Indian Festival 2020 - Electronics
Research

| More

Supreme Industries - Perfect recipe for rerating; upgrade to BUY - ICICI Securities

Posted On: 2020-09-22 21:44:08


We upgrade Supreme Industries (SIL) to BUY driven by a) faster-than-expected recovery post Covid-19 led lockdown - mere 3.4%/3.7% volume/value decline in Jul and Aug'20 (Source: Chairman's speech at its recently concluded AGM); b) higher (double-digit) growth expectations post FY21 in its core segments - plastic piping and SILAPULIN; c) likely improvement in asset turns over the next 2-3 years with huge capex over FY20-FY21 going into the production next year; d) reducing dependence on commodity-led industrial and consumer product segments; d) higher EBITDA margin trajectory driven by increasing share of VAP revenues, further decentralisation of plants, superior product mix and operating leverage; and f) fast improving RoCEs led by strong traction in profitability and higher fixed asset turns.

- Upgrade to BUY with a target price of Rs1,640. Considering faster-than-expected recovery and improving visibility in its core segments - plastic piping and SILPAULIN, we revise our revenue and PAT estimates upwards by 8.9%/5.7% and 24.9%/11.7%, respectively for FY21E/FY22E. We now expect the company's revenue and core PAT to exhibit a 6.9% and 15.7% CAGR over FY20-FY22, respectively. We upgrade SI to BUY with a target price of Rs1,640 (Rs1,135 earlier) valuing it at 35x FY22E core earnings.

- Volume growth at an inflection point. SIL is likely to report a muted 3.9%/4.6% volume/revenue CAGR over FY17-FY21. The muted growth is largely attributed to single digit volume growth (6.2% CAGR) in its plastic piping segment and flat to negative volume CAGR in other segments. With growth likely to accelerate in its plastic piping (driven by likely accelerated industry consolidation post Covid-19 and expected decentralisation of its manufacturing footprint) and packaging product segment (driven by easing competitive intensity in its SILPAULIN segment in particular), we expect SIL's volumes to be an inflection point and register a double-digit volume growth CAGR over the next 2-3 years post FY21E.

- EBITDA margins to improve led by multiple levers. We expect SIL's EBITDA margins to improve in 15.5-16.5% range driven by a) increasing share of VAP revenues led by likely scaling up of its CPVC pipes and SILPAULIN segment (with cross plastic film project likely to commence production next year), b) further decentralisation of its manufacturing footprint (with plastic piping greenfield projects in Telangana and Orissa going into production next year), c) superior product mix (plastic piping and packaging product segment to contribute over 80% of its overall revenues by FY22E), d) recent fixed cost rationalisation and e) operating leverage.

- RoCEs to cross 25%+ by FY22E. Healthy balance sheet (driven by strict working capital management and high FCF generation), expected improvement in its asset turns (recent capex going into production over the next 2-3 quarters), incremental capex in higher RoCE generating (plastic piping and cross plastic film) segments and likely traction in earnings is expected to drive its overall RoCEs to 26.6% in FY22E and ~30% in FY23E. This, we believe, would lead to further rerating in the stock going forward.

Shares of SUPREME INDUSTRIES LTD. was last trading in BSE at Rs.1407.05 as compared to the previous close of Rs. 1450. The total number of shares traded during the day was 1828 in over 347 trades.

The stock hit an intraday high of Rs. 1445 and intraday low of 1381.1. The net turnover during the day was Rs. 2564378.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com

Amazon Great Indian Festival 2020 - Mobiles


Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only. www.equitybulls.com, its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. www.equitybulls.com or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.





Other Headlines:

Reiterate ADD on Amara Raja Batteries - Pent-up demand leads to healthy 2Q - HDFC Securities

Maintain REDUCE on Titan - Reasonable print - HDFC Securities

REDUCE on RBL Bank - Some positives, but key concerns remain - HDFC Securities

Maintain REDUCE on Marico - Saffola shines with PCNO recovery, muted margin - HDFC Securities

Maintain ADD on Dr. Reddy's Labs - Good quarter, lower SG&A cost is encouraging - HDFC Securities

Piramal Enterprises - Acquisition of stake from JV partner - Angel Broking

Maintain BUY on Axis Bank - Provision buffers strengthened (further) - HDFC Securities

AU Small Finance Bank - Q2FY21 Result - Angel Broking

L&T - Q2FY21 - Angel Broking

RBL Bank - Q2FY21 Result - Angel Broking

Axis Bank - Q2FY21 Result - Angel Broking

Marico Ltd - Q2FY21 Result Update - YES Securities

Titan Company Ltd - Q2FY21 Result Update - YES Securities

Axis Bank Limited - Q2FY21 Result Update - YES Securities

RBL Bank Limited - Q2FY21 Result Update - YES Securities

Multi Commodity Exchange of India - Operating leverage aids strong EBITDA performance - ICICI Securities

Titan Company - Faster-than-expected recovery - ICICI Securities

Marico - Strong performance across portfolio - ICICI Securities

Heritage Foods - Lower procurement prices leading to highest EBITDA margin in past decade - ICICI Securities

Axis Bank - Strong core again utilised to create provisioning buffer - ICICI Securities

Supreme Industries - Beat on all counts - ICICI Securities

GSK Pharmaceuticals - Recovery from COVID-19 impact - ICICI Securities

Hero MotoCorp - Solid demand recovery expectations priced in - ICICI Securities

Cement - Demand / prices improve further in Oct'20 - ICICI Securities

CEAT - Replacement demand drives outperformance - ICICI Securities

Dr. Reddy's Laboratories - Outperformance continues - ICICI Securities

ICICI Prudential Life Insurance - VNB trajectory in-line despite YoY dip in protection in Q2 - ICICI Securities

Bharti Airtel - Q2FY21 Result Update - ICICI Securities

Marico - Q2FY21 Result Update - ICICI Securities

Larsen & Toubro - Q2FY21 First Cut - ICICI Securities

Sanofi India - Q3CY20 Company Update - ICICI Securities

Adani Ports and SEZ - Quant Pick - ICICI Securities

Nippon Life India AMC - Q2FY21 Result Update - ICICI Securities

Tata Motors - Q2FY21 Result Update - ICICI Securities

Derivatives Strategy - Mahanagar Gas - Positional Future - ICICI Securities

Supreme Industries - Q2FY21 First Cut - ICICI Securities

Dr Reddy's Laboratories - Q2FY21 First Cut - ICICI Securities

Marico Ltd - Q2FY21 First Cut - ICICI Securities

Apcotex Industries - Q2FY21 First Cut - ICICI Securities

V-Guard Industries - Q2FY21 First Cut - ICICI Securities

Titan Company - Q2FY21 First Cut - ICICI Securities

Navin Fluorine - Q2FY21 First Cut - ICICI Securities

PI Industries - Q2FY21 First Cut - ICICI Securities

L&T - Q2FY21 Earnings First Cut: Beat on EBITDA margins - YES Securities

Bharti Airtel - Q2FY21 result - Angel Broking

Dr.Reddy's Lab - Q2FY21 - Angel Broking

BUY on Mahindra & Mahindra Financial Services - Remains an inexpensive rural play - HDFC Securities

Radico Khaitan - Q2FY21 - Angel Broking

Maintain BUY on CDSL - Firing on all cylinders - HDFC Securities

REDUCE on Nippon Life India Asset Management - Market share stabilising - HDFC Securities







Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019